Radiopharm Theranostics
(ASX) RAD
Radiopharm Theranostics Financials at a Glance
Market Cap
$77.97M
Revenue (TTM)
$15.09M
Net Income (TTM)
$86.86M
EPS (TTM)
$-0.02
P/E Ratio
-1.45
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Price
$0.02
Volume
607,068
Open
$0.02
Price
$0.02
Volume
607,068
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.02 - $0.04
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Price
$0.02
Volume
607,068
Open
$0.02
Previous Close
$0.02
Daily Range
$0.02 - $0.02
52-Week Range
$0.02 - $0.04
RAD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Radiopharm Theranostics
Industry
Biotechnology
Sector
Health CareCEO
Riccardo Canevari
Website
radiopharmtheranostics.comHeadquarters
Carlton, VIC 3053, AU
RAD Financials
Key Financial Metrics (TTM)
Gross Margin
2%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-86%
Return on Capital
-66%
Return on Assets
-49%
Earnings Yield
-68.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$77.97M
Shares Outstanding
3.54B
Volume
607.07K
Short Interest
0.00%
Avg. Volume
3.67M
Financials (TTM)
Gross Profit
$9.81M
Operating Income
$38.17M
EBITDA
$31.65M
Operating Cash Flow
$36.65M
Capital Expenditure
$0.00
Free Cash Flow
$36.65M
Cash & ST Invst.
$29.12M
Total Debt
$0.00
Radiopharm Theranostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.39M
-65.9%
Gross Profit
$1.25M
+20.3%
Gross Margin
-90.30%
N/A
Market Cap
$77.97M
N/A
Market Cap/Employee
$5.57M
N/A
Employees
14
N/A
Net Income
$26.97M
-8.9%
EBITDA
$29.75M
-9.6%
Quarterly Fundamentals
Net Cash
$34.52M
+1722.4%
Accounts Receivable
$11.36M
+157.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-49.29%
N/A
Return on Invested Capital
-65.55%
N/A
Free Cash Flow
$22.67M
-92.6%
Operating Cash Flow
$22.67M
-92.6%